reference/3132742

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3132742

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	142
issn	0165-4608
issueIdentifier	2
pageRange	139-142
publicationName	Cancer Genetics and Cytogenetics
startingPage	139
bibliographicCitation	Falchi L, Rege-Cambrin G, Fava C, Donti E, Luzi D, Giugliano E, Gubbiotti M, Schippa M, Liberati AM. Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution. Cancer Genet Cytogenet. 2010 Jun;199(2):139–42. doi: 10.1016/j.cancergencyto.2010.02.008. PMID: 20471518.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_999ad28615ab150a055dfa2efa83a251 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd023fbe62d76f2ac212e563fa9d1cfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d26881cbc3544e70aacc87ffcf989fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4896-981X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e649c67d1fed67a6ef8e0cf5c7f7d963 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ac9a4c86f183a63b0327b5ae18fc45e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b464d6c81ad3cb4cbb2a10bfe980b503 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1531-3838 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15bf6a351a078dccbb13ef50b8fd8a9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b80379c8c7823a7abb3982088b1076c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2c60937d58b016989acb994c21d6411
date	201006
identifier	https://doi.org/10.1016/j.cancergencyto.2010.02.008 https://pubmed.ncbi.nlm.nih.gov/20471518
isPartOf	https://portal.issn.org/resource/ISSN/0165-4608 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2778
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution
discusses	http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0016884
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002999Q000473 http://id.nlm.nih.gov/mesh/D002999Q000187 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D015464Q000235 http://id.nlm.nih.gov/mesh/D015464Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015464Q000473 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007621 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7277 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103

Total number of triples: 61.